Forbes

Sarah Rafferty, who played Donna on Suits, talks about losing her grandmother to Alzheimer's Disease and helping her mother care for her father who also has AD.

Nigeria confirmed its first Bundibugyo Ebola case after a traveler spent nine days treated for malaria. Why border screening cannot stop the virus from spreading.

Holmes says in Nathan Fielder’s documentary on her that she doesn’t ever recall lying. Forbes went back to the archives to fact-check that claim and it doesn’t hold up.

Think you need a testosterone checked? A physician explains what symptoms should prompt testosterone screening, how to interpret results, and when to consider treatment.

Sunfish CEO Angela Rastegar uses AI and 2 million clinic data points to price IVF and egg freezing, backed by refunds, as the startup weighs its next raise.

Elevance Health reported third quarter net income of $1.36 billion as the company’s Medicare and Obamacare costs fell, prompting an improved full-year earnings outlook.

New published estimates attach a lifetime risk of dying to each level of drinking. A doctor explains what the numbers do and don’t show.

After a promising pre-season, Sacramento King Ben Simmons was aiming to play in his first NBA regular season game since April 2025 but suffered an Achilles tendon tear.

It's not completely clear what happened with the care of Philadelphia Eagles quarterback Jalen Hurts, who developed deep vein thromboses and pulmonary embolisms.

Business school is an easy target, but it isn’t the disaster that Christopher Marquis says that it is in the pages of the New York Times.

In 2024, 6,488 American veterans died by suicide. But the most consequential finding in a new Report is that nearly 1/2 of all vets are not even engaged with the system.

Neurotech prosthetics are the first serious foray into robotics . Phantom Neuro and BIOS new clinical implantations show a side of the BCI market with broader applications.

AI-designed T-cell receptors improved cancer-cell killing in the lab and tumor control in mice, pointing toward more effective engineered T-cell therapies.